Literature DB >> 23128895

Retrospective analysis of linac-based radiosurgery for arteriovenous malformations and testing of the Flickinger formula in predicting radiation injury.

I A Cetin1, R Ates, J Dhaens, G Storme.   

Abstract

BACKGROUND AND
PURPOSE: The aim of the study was to validate the use of linac-based radiosurgery in arteriovenous malformation (AVM) patients and to predict complications using an integrated logistic formula (ILF) in comparison with clinical outcomes. PATIENTS AND METHODS: The results of radiosurgery in 92 AVM patients were examined. All patients were treated with linac-based radiosurgery. Of these, 70 patients were followed for 12-45 months (median, 24 months) and were analyzed. The treated volume varied from 0.09 to 26.95 cm(³) (median, 2.3 cm(³)) and the median marginal dose was 20 Gy (range, 10.4-22). The median 12-Gy volume was 9.94 cm(³) (range, 0.74-60.09 cm(³)). Patients and lesion characteristics potentially affecting nidus obliteration and excellent outcome were evaluated by performing a log-rank test and univariate and multivariate analyses. The risk for radiation injury (RRI) was calculated with an integrated logistic formula. The predictive power of the RRI was assessed by calculating the area under the receiver operating characteristic (ROC) curve.
RESULTS: Follow-up magnetic resonance (MR) angiography revealed complete AVM obliteration in 56 of 70 patients. The MR angiography confirmed an obliteration rate of 80%. The annual hemorrhage rate was 1.4% for the first 2 years after radiosurgery and 0% thereafter. The number of patients with an excellent outcome was 48 (68%). Factors associated with better obliteration were higher radiation dose to the lesion margins [12-Gy volume (V12) >10 cm(³)], small volume, and a Pollock-Flickinger score less than 1.49; those predicting excellent outcomes were V12<10 cm(³), small volume, and Pollock-Flickinger score less than 1.49, as determined by multivariate analyses. Factors associated with radiation injury were V12>10 cm(³ )(p=0.03) and volume greater than 2 cm(³) (p=0.001), as determined by a univariate analysis. The analyses showed an ROC of 0.66.
CONCLUSION: These data suggest that linac-based radiosurgery is effective. In terms of obliteration, excellent outcomes, and especially radiation injury, V12 and volume should be considered. The Flickinger formula seems to be applicable to Novalis-treated patients, but long-term follow-up is necessary for definite conclusions.

Entities:  

Mesh:

Year:  2012        PMID: 23128895     DOI: 10.1007/s00066-012-0180-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  46 in total

1.  Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group.

Authors:  J C Flickinger; D Kondziolka; L D Lunsford; A Kassam; L K Phuong; R Liscak; B Pollock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-15       Impact factor: 7.038

2.  Stereotactic LINAC radiosurgery for the treatment of brainstem cavernomas.

Authors:  M Fuetsch; F El Majdoub; M Hoevels; R P Müller; V Sturm; M Maarouf
Journal:  Strahlenther Onkol       Date:  2012-04       Impact factor: 3.621

3.  Analysis of treatment failure after radiosurgery for arteriovenous malformations.

Authors:  T L Ellis; W A Friedman; F J Bova; P S Kubilis; J M Buatti
Journal:  J Neurosurg       Date:  1998-07       Impact factor: 5.115

4.  Risk analysis of linear accelerator radiosurgery.

Authors:  J Voges; H Treuer; V Sturm; C Büchner; R Lehrke; M Kocher; S Staar; J Kuchta; R P Müller
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-12-01       Impact factor: 7.038

5.  Factors influencing the risk for complications following Gamma Knife radiosurgery of cerebral arteriovenous malformations.

Authors:  B Karlsson; I Lax; M Söderman
Journal:  Radiother Oncol       Date:  1997-06       Impact factor: 6.280

6.  Stereotactic radiosurgery for intracranial arteriovenous malformations using a standard linear accelerator.

Authors:  J S Loeffler; E Alexander; R L Siddon; W M Saunders; C N Coleman; K R Winston
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-09       Impact factor: 7.038

7.  Linac radiosurgery for cerebral arteriovenous malformations: results in 169 patients.

Authors:  M Schlienger; D Atlan; D Lefkopoulos; L Merienne; E Touboul; O Missir; F Nataf; H Mammar; K Platoni; P Grandjean; J N Foulquier; J Huart; C Oppenheim; J F Meder; E Houdart; J J Merland
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-15       Impact factor: 7.038

8.  Embolization before radiosurgery reduces the obliteration rate of arteriovenous malformations.

Authors:  Yuri M Andrade-Souza; Meera Ramani; Daryl Scora; May N Tsao; Karel terBrugge; Michael L Schwartz
Journal:  Neurosurgery       Date:  2007-03       Impact factor: 4.654

9.  Linac-based stereotactic radiosurgery for brain arteriovenous malformations.

Authors:  S Blamek; R Tarnawski; L Miszczyk
Journal:  Clin Oncol (R Coll Radiol)       Date:  2011-04-17       Impact factor: 4.126

10.  Patient outcomes after arteriovenous malformation radiosurgical management: results based on a 5- to 14-year follow-up study.

Authors:  Bruce E Pollock; Deborah A Gorman; Robert J Coffey
Journal:  Neurosurgery       Date:  2003-06       Impact factor: 4.654

View more
  5 in total

1.  Predictors for occlusion of cerebral AVMs following radiation therapy : Radiation dose and prior embolization, but not Spetzler-Martin grade.

Authors:  Stefan Knippen; Florian Putz; Sabine Semrau; Ulrike Lambrecht; Arzu Knippen; Michael Buchfelder; Sven Schlaffer; Tobias Struffert; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2016-10-18       Impact factor: 3.621

2.  Intracranial stereotactic radiosurgery with an adapted linear accelerator vs. robotic radiosurgery: Comparison of dosimetric treatment plan quality.

Authors:  Harald Treuer; Moritz Hoevels; Klaus Luyken; Veerle Visser-Vandewalle; Jochen Wirths; Martin Kocher; Maximilian Ruge
Journal:  Strahlenther Onkol       Date:  2014-11-22       Impact factor: 3.621

3.  Fast and high temperature hyperthermia coupled with radiotherapy as a possible new treatment for glioblastoma.

Authors:  Giovanni Borasi; Alan Nahum; Margarethus M Paulides; Gibin Powathil; Giorgio Russo; Laura Fariselli; Debora Lamia; Roberta Cirincione; Giusi Irma Forte; Cristian Borrazzo; Barbara Caccia; Elisabetta di Castro; Silvia Pozzi; Maria Carla Gilardi
Journal:  J Ther Ultrasound       Date:  2016-12-08

Review 4.  Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review.

Authors:  Maxime Loo; Jean-Baptiste Clavier; Justine Attal Khalifa; Elisabeth Moyal; Jonathan Khalifa
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

Review 5.  Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.

Authors:  Michael T Milano; Jimm Grimm; Andrzej Niemierko; Scott G Soltys; Vitali Moiseenko; Kristin J Redmond; Ellen Yorke; Arjun Sahgal; Jinyu Xue; Anand Mahadevan; Alexander Muacevic; Lawrence B Marks; Lawrence R Kleinberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-09-11       Impact factor: 8.013

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.